Podcasts about efx

S&P Futures are slightly higher this morning with earnings announcements in focus. UAL, JBHT are moving higher after their releases. Semiconductor stocks are mostly higher this morning. AMSL shares are falling after technical glitch release earnings earlier than expected. After the bell today watch for earnings from AA, CSX, DFS, EFX, LVS & STLD. The ECB rate decision is scheduled for tomorrow. China is scheduled to hold another economic briefing tomorrow on its property market. In Europe, markets are mixed to lower with weakness in luxury and tech stocks. Oil prices are continuing to move lower this morning.

After 4 successful albums from 1987-1992, Chubb Rock went on a hiatus before making a comeback in 1997 with this weeks' topic album The Mind. Though hip-hop had drastically changed prior to his return, The Chubster showed he hadn't missed a step, making for an enjoyable play, especially if you're a Chubb Rock fan. https://www.tiktok.com/@brandonhetzel996?_t=8pLUOuiLtPf&_r=1 https://www.instagram.com/str8_the_clippa?igsh=cTBzNnFhenRkN3Nl&utm_source=qr https://www.facebook.com/profile.php?id=100086006336425&mibextid=LQQJ4d

Check out our new sister channel/show called 20 Minute Travel! - https://www.youtube.com/@20minutetravel You can also listen to 20 Minute Travel as a podcast: Spotify Apple Podcasts Episode Description: As a reminder you can watch this show as well at: http://www.YouTube.com/milestomemories This week a lot of back and forth happened on social media as people debated everything from "000" roulette to the current state of the Vegas Sphere. With its losses mounting, will the most iconic venue in Sin City continue on to financial success or is its debt too much of a burden to handle. In other news another new Hollywood studio may be coming to Vegas as Warner Brothers throws their hat in the ring. We also discuss the new Janet Jackson residency, a 1983 Vegas timelapse, Rick Springfield and EFX, what's left of the Mirage volcano, Venetian joining the union and how Bellagio fought back against social media rumors. Episode Guide: 0:00 Vegas pedicab driver - Worst job in Vegas? 0:34 Hollywood East is coming - Warner Brothers announces new Vegas movie studio 3:56 Venetian/Palazzo workers join the Culinary Union 5:08 Inside Venetian's renovated conference center - Big improvement 5:40 Little League World Series - Vegas area team makes the U.S. semifinals 6:26 Bellagio buffet controversy - Not closing despite rumors 7:47 Does Bellagio need a food hall or more lower-end dining? 8:42 Is 7 Magic Mountains moving for airport expansion? 10:28 Very cool 1983 Las Vegas timelapse 11:35 Rick Springfield coming to Fremont + EFX lookback 13:04 Janet Jackson Resorts World residency confirmed 13:50 Sphere losses mounting - Are they on the road to success? 15:50 Sphere's plan to diversify including new U2 concert movie 17:22 Rio sending out even more comp offers to Caesars players 18:46 “000” Roulette controversy - Are Vegas casinos misleading customers? 20:09 Why Vegas casinos use their logo instead of a “000" 21:50 What's left of Mirage's iconic volcano - Trigger warning! About the Show: Each week tens of thousands of people tune into our MtM Vegas news shows at http://www.YouTube.com/milestomemories. We do two news shows weekly on YouTube with this being the audio version. Never miss out on the latest happenings in and around Las Vegas! Enjoying the podcast? Please consider leaving us a positive review on your favorite podcast platform! You can also connect with us anytime at podcast@milestomemories.com.  You can subscribe on Apple Podcasts, Google Podcasts, Spotify or by searching "MtM Vegas" or "Miles to Memories" in your favorite podcast app. Don't forget to check out our travel/miles/points podcast as well!

In this episode, we dive into the launch of Bloom UI with its creator, Chris Gregori. Chris shares his motivations behind Bloom, an opinionated extension of Phoenix core components, aimed at simplifying UI development for Elixir and LiveView projects. We discuss its command-line utility for generating components, current features like avatars and marketing layouts, and potential future directions including expanded components and web component integration. Highlights include Chris's journey with Elixir, contributions from the community, and a strong emphasis on accessibility. Plus, we cover news on Livebook 0.13.x release, the viral "2 Million Checkboxes" project by Peter Ullrich, Tyler Young's updated Parameterized Tests, and more! Show Notes online - http://podcast.thinkingelixir.com/210 (http://podcast.thinkingelixir.com/210) Elixir Community News - https://github.com/livebook-dev/livebook/blob/v0.13/CHANGELOG.md (https://github.com/livebook-dev/livebook/blob/v0.13/CHANGELOG.md?utm_source=thinkingelixir&utm_medium=shownotes) – Livebook 0.13.x release notes. - https://github.com/livebook-dev/livebook/pull/2629 (https://github.com/livebook-dev/livebook/pull/2629?utm_source=thinkingelixir&utm_medium=shownotes) – FLAME support added by Chris McCord. - https://github.com/livebook-dev/livebook/pull/2636 (https://github.com/livebook-dev/livebook/pull/2636?utm_source=thinkingelixir&utm_medium=shownotes) – List of connected distributed nodes displayed on the Runtime panel. - https://github.com/livebook-dev/livebook/pull/2577 (https://github.com/livebook-dev/livebook/pull/2577?utm_source=thinkingelixir&utm_medium=shownotes) – Drag-and-drop support for xlsx-format. - https://github.com/livebook-dev/livebook/pull/2519 (https://github.com/livebook-dev/livebook/pull/2519?utm_source=thinkingelixir&utm_medium=shownotes) – José Valim added LIVEBOOKCLUSTER=auto to configure the cluster on Fly.io. - The code editor now uses CodeMirror with improved design and performance. - Cell evaluation time shows when the cell is stale or aborted. - Hubs renamed to Workspaces. - Elixir 1.17.1 and OTP 27 used in Docker image and desktop app. - Long names mode for distribution used for easier clustering. - Congratulations to the team and contributors with special mention of Jonatan Kłosko. - https://www.reddit.com/r/elixir/comments/1dqg0kr/efxalibrarytodeclarativelywritetestable/ (https://www.reddit.com/r/elixir/comments/1dqg0kr/efx_a_library_to_declaratively_write_testable/?utm_source=thinkingelixir&utm_medium=shownotes) – Introduction to Efx, a library to declaratively write testable effects. - https://github.com/bravobike/efx (https://github.com/bravobike/efx?utm_source=thinkingelixir&utm_medium=shownotes) – GitHub repository for Efx library. - https://x.com/PJUllrich/status/1806646221592809482 (https://x.com/PJUllrich/status/1806646221592809482?utm_source=thinkingelixir&utm_medium=shownotes) – Peter Ullrich's tweet about "2 Million Checkboxes". - https://x.com/PJUllrich/status/1806252631179850046 (https://x.com/PJUllrich/status/1806252631179850046?utm_source=thinkingelixir&utm_medium=shownotes) – Background on "one million checkboxes" written in Python + React. - https://twomillioncheckboxes.com/ (https://twomillioncheckboxes.com/?utm_source=thinkingelixir&utm_medium=shownotes) – Live website for "two million checkboxes" hosted on Fly.io. - https://x.com/PJUllrich/status/1806649316963996153 (https://x.com/PJUllrich/status/1806649316963996153?utm_source=thinkingelixir&utm_medium=shownotes) – Peter Ullrich's tweet showing hardware performance and updates. - https://github.com/PJUllrich/twomillioncheckboxes (https://github.com/PJUllrich/twomillioncheckboxes?utm_source=thinkingelixir&utm_medium=shownotes) – GitHub project for "two million checkboxes" site. - https://x.com/TylerAYoung/status/1806794015892996503 (https://x.com/TylerAYoung/status/1806794015892996503?utm_source=thinkingelixir&utm_medium=shownotes) – Update and rename to Parameterized Tests by Tyler Young. - https://github.com/elixir-lang/elixir/blob/main/CHANGELOG.md#v1180-dev (https://github.com/elixir-lang/elixir/blob/main/CHANGELOG.md#v1180-dev?utm_source=thinkingelixir&utm_medium=shownotes) – Elixir 1.18 changelog including parameterized tests in ExUnit. - https://github.com/s3cur3/parameterized_test (https://github.com/s3cur3/parameterized_test?utm_source=thinkingelixir&utm_medium=shownotes) – Parameterized Tests GitHub repository. - https://github.com/elixir-lang/elixir/pull/13618 (https://github.com/elixir-lang/elixir/pull/13618?utm_source=thinkingelixir&utm_medium=shownotes) – Elixir pull request for parameterized tests feature. - https://farens.me/blog/how-to-integrate-tabler-icons-into-your-phoenix-project (https://farens.me/blog/how-to-integrate-tabler-icons-into-your-phoenix-project?utm_source=thinkingelixir&utm_medium=shownotes) – Blog post by Florian Arens on integrating Tabler Icons into Phoenix projects. - https://tabler.io/icons (https://tabler.io/icons?utm_source=thinkingelixir&utm_medium=shownotes) – Tabler Icons website with 5325 free and open-source icons. - https://github.com/acalejos/flint (https://github.com/acalejos/flint?utm_source=thinkingelixir&utm_medium=shownotes) – Introduction to Flint by Andres Alejos, a library for Ecto embeddedschemas. - https://x.com/germsvel/status/1808080927177814037 (https://x.com/germsvel/status/1808080927177814037?utm_source=thinkingelixir&utm_medium=shownotes) – German Velasco's tweet on an intro to tracing on the BEAM using the Recon library. - https://www.elixirstreams.com/tips/tracing-with-recon (https://www.elixirstreams.com/tips/tracing-with-recon?utm_source=thinkingelixir&utm_medium=shownotes) – ElixirStreams post on tracing with Recon. - https://github.com/ferd/recon/ (https://github.com/ferd/recon/?utm_source=thinkingelixir&utm_medium=shownotes) – Recon GitHub repository. - https://2024.elixirconf.com/ (https://2024.elixirconf.com/?utm_source=thinkingelixir&utm_medium=shownotes) – ElixirConf 2024 Preview - August 28-30 with notable speakers and topics. Do you have some Elixir news to share? Tell us at @ThinkingElixir (https://twitter.com/ThinkingElixir) or email at show@thinkingelixir.com (mailto:show@thinkingelixir.com) Discussion Resources - https://www.liveviewcookbook.com/ (https://www.liveviewcookbook.com/?utm_source=thinkingelixir&utm_medium=shownotes) – My LiveView e-book The LiveView Cookbook - https://youtube.com/@codestirring (https://youtube.com/@codestirring?utm_source=thinkingelixir&utm_medium=shownotes) – YouTube Elixir Tutorial Channel - https://twitch.tv/@codestirring (https://twitch.tv/@codestirring?utm_source=thinkingelixir&utm_medium=shownotes) – Twitch streaming channel - https://uini.io - Uini.io (Latest side project - an AI powered user interview widget) (https://uini.io - Uini.io (Latest side project - an AI powered user interview widget)?utm_source=thinkingelixir&utm_medium=shownotes) - https://twitter.com/codestirring/status/1785769316304228590 (https://twitter.com/codestirring/status/1785769316304228590?utm_source=thinkingelixir&utm_medium=shownotes) - https://bloom-ui.fly.dev/ (https://bloom-ui.fly.dev/?utm_source=thinkingelixir&utm_medium=shownotes) – Site with links and shows off how Bloom looks and works - https://github.com/chrisgreg/bloom (https://github.com/chrisgreg/bloom?utm_source=thinkingelixir&utm_medium=shownotes) – GitHub project for Bloom - "The opinionated extension to Phoenix core_components" - https://www.w3.org/WAI/standards-guidelines/wcag/ (https://www.w3.org/WAI/standards-guidelines/wcag/?utm_source=thinkingelixir&utm_medium=shownotes) - https://github.com/angelikatyborska/a11y-audit-elixir/tree/main (https://github.com/angelikatyborska/a11y-audit-elixir/tree/main?utm_source=thinkingelixir&utm_medium=shownotes) - https://github.com/ash-project/igniter (https://github.com/ash-project/igniter?utm_source=thinkingelixir&utm_medium=shownotes) - https://dashbit.co/blog/web-apps-have-client-and-server-state (https://dashbit.co/blog/web-apps-have-client-and-server-state?utm_source=thinkingelixir&utm_medium=shownotes) - https://developer.mozilla.org/en-US/docs/Web/API/Web_components (https://developer.mozilla.org/en-US/docs/Web/API/Web_components?utm_source=thinkingelixir&utm_medium=shownotes) - https://lit.dev/ (https://lit.dev/?utm_source=thinkingelixir&utm_medium=shownotes) Guest Information - https://twitter.com/codestirring (https://twitter.com/codestirring?utm_source=thinkingelixir&utm_medium=shownotes) – on Twitter - https://github.com/chrisgreg/ (https://github.com/chrisgreg/?utm_source=thinkingelixir&utm_medium=shownotes) – on Github - https://www.chriis.dev/ (https://www.chriis.dev/?utm_source=thinkingelixir&utm_medium=shownotes) – Blog Find us online - Message the show - @ThinkingElixir (https://twitter.com/ThinkingElixir) - Message the show on Fediverse - @ThinkingElixir@genserver.social (https://genserver.social/ThinkingElixir) - Email the show - show@thinkingelixir.com (mailto:show@thinkingelixir.com) - Mark Ericksen - @brainlid (https://twitter.com/brainlid) - Mark Ericksen on Fediverse - @brainlid@genserver.social (https://genserver.social/brainlid) - David Bernheisel - @bernheisel (https://twitter.com/bernheisel) - David Bernheisel on Fediverse - @dbern@genserver.social (https://genserver.social/dbern)

Credits Banner: Viswamitra Creations Cast: Mohan Babu, NTR, Priyamani, Mamata Mohandas, Kushboo, Rambha, Jaya Prakash Reddy, Narendra Jha, Rajiv Kanakala, Naresh, Ali, Brahmanandam, MS Narayana, Camera: Senthil Kumar Dialogues: M Ratnam Music: MM Keeravani Editing: Kotagiri Venkateswara Rao Art: Anand Sai Story: Vijayendra Prasad Presents: Rama Rajamouli Screenplay - direction: SS Rajamouli Producer: Cherry and Urmila Gunnam Release date: 15 August 2007 Interesting Facts - Tell us about how Yamadonga project happened? In response to our offer to direct a film for us, Rajamouli called me and Urmila Gangaraju one day and said that he would be directing a film for us on his banner Viswamitra creations. He wanted us to be the producers of his first venture on Viswamitra banner. Yama Donga, one of the most eagerly awaited premium product of Tollywood is all set to hit the screens very shortly. This film is by far the costliest movies made in the Telugu film industry. This film boasts of the biggest indoor set erected so far in whole of Asia and incidentally is the costliest individual set. This Yama Lokam set was erected over period of 90 days with 300 workers working on the set day and night. The magnitude of the set was so much that it took almost another one and half month to dismantle the same. This set was erected in Ramoji Film City and the no.of shooting days in this set was 42 days. Apart from this the other sets erected for four songs, the set of the Hero House and the Heroine House are also done with lot of richness and grand taste.  The biggest set in RFC was erected for Vaaji song in Sivaji and it occupied only 60% of the floor. The Yamalokam set occupied 100% of the floor. We used 15 generators at a time to light up the floor. It took 4 days to set the lighting to that floor. Senthil Kumar used the best available equipment to shoot this film. Since Yamalokam set demanded a great amount of lighting, we procured almost all available lighting equipment from Hyderabad movie infrastructure providers. We had to borrow some of the lighting equipment from Chennai too. Graphics work plays a very vital role because it is a socio fantasy. We employed various e-fx companies. Adel Edeli - a renowned 3D animator from Iran - did the 3-D work for the exterior of Yamalokam. EFX studio did the major work (around 90%) of the graphics part. They have been working on the film from April to August. Rajamouli did online editing and made sure that graphics work is done simultaneously along with the shooting. A team of 80 professionals spread over three outsourcing houses spearheaded by EFX are working on the graphics and the production house is confident of coming out with the most impressive visuals.  Keeravani started the work on 2 July and will complete it on 7 August. It is taking over a month. Keeravani is immensely enjoying rerecording as it is a challenging task to work for a socio-fantasy It is partly true. Prabhas did the role of Viswamitra. But not for Yamadonga film. When Rajamouli wanted to design the logo of Viswamitra Creations, he needed a model for Viswamitra photo. He requested Prabhas as his physique is very good. Prabhas obliged for a photo shoot. The designer cut the physique of Prabhas and inserted in the logo of Viswamitra creations. We started the shooting on 2 January 2007 and completed it by the end of July. It took us 148 working days spread over a span of seven months. We exposed around 2 lakhs feet of negative. We shot most of the film indoors by erecting massive sets in Ramoji Film City, Annapurna studios and Rama Naidu studios (Nanakram Guda). Climax was shot in Talakona forest. A song and some scenes were shot at Golconda Fort in Hyderabad.  Audio launched on July 14h, 2007 at Hotel Marriot in Hyderabad. Finally movie released on  Movie was a hit at the box office collecting 29 crores share and ran for 50 days in 400 centers and 100 days in 61 centers. 3rd consecutive hit in SSR NTR combination. 

S&P Futures are slightly lower this morning. Multiple companies delivered earnings beats since yesterdays close including ARM, BLBD, DIS, EFX, PAYC, RPD & WYNN. This afternoon we will be hearing from CPRI, MHK, AFRM, EXPE, PINS, NET & TTWO. Markets will be keeping an eye on Capitol Hill today. Tres Sec Janet Yellen will testify at a Senate Banking committee hearing. Pharma CEO's will be appearing before a Senate panel on prescription drug prices. The Supreme Court is hearing arguments today whether Trump can be disqualified from running of office. In Europe, stocks are mainly higher. Oil prices are showing gains of approximately 1%.

"Son of a Black Panther" the show title this week, is lifted from an outstanding new album by "Bam Bam,s Boogie", 1 of 2 must hear new LPs to drop right about now, the other being "Spiral Dance" from the mighty "DMX Crew". 2 tracks from each & another cut from Mr "Rennie Pilgrem`s" current top notch long player "Dirty World" upfront Electronica, Amapiano, Rave for real, Afro House & an array of Voice Bytes, EFX, Lickshots & Toaster bits, cross genre, cross bpm. Creating new fusions, seeding tommorows new grooves, this is Dub Intervention.This show was first broadcast on the 3rd of February, 2024For more info and tracklisting, visit: https://thefaceradio.com/dub-intervention/Tune into new broadcasts of Dub Intervention, Saturday from 8 - 10 PM EST / 1 - 3 AM GMT (Sunday).Dig this show? Please consider supporting The Face Radio: http://support.thefaceradio.com Support The Face Radio with PatreonSupport this show http://supporter.acast.com/thefaceradio. Join the family at https://plus.acast.com/s/thefaceradio. Hosted on Acast. See acast.com/privacy for more information.

On this week's episode of the Escape Your Limits podcast, we are joined Paul Byrne, an innovative leader whose focus on progression and innovation has been instrumental in shaping the fitness industry as we know it. Today, Paul is a Partner at Harrison Co, a consumer-focused investment bank helping clients make the right strategic business decisions to capitalize on the rapidly changing consumer economy. Recently the company released a report exploring ‘The Impact and Opportunities of GLP-1s for the Fitness and Wellness Industry'.  In this podcast we dive into the detail, drawing on Paul's extensive firsthand industry experience to understand how fitness operators can optimize the introduction of these new ‘miracle' weight loss drugs. Paul is perfectly placed to comment, thanks to his extensive experience of driving innovation and growth in the fitness industry. Over the course twenty years, Paul transformed Precor from a ‘one trick pony' into a multi-product world renowned fitness company over the course of a twenty-year period. In addition to bringing to market iconic equipment innovations including the elliptical (EFX®) and the adaptive motion trainer (AMT), during his time as President, Paul also kick-started the gym floor technology revolution with the introduction of Precor's Preva - a personalized fitness technology providing tailored workouts, popular apps and live tv to cardio machine users.  There are few people who know more about the need to adapt to changing market conditions or the value in keeping a head of the curve with products and services relevant to the ever-changing needs and wants of the consumer. In this podcast, Paul talks about: The rationale behind the report. Defining GLP-1s – how they work, what benefits they deliver. How GLP-1s can be accessed. The disruption GLP-1s will cause to the fitness, wellness, weight loss and other industries. Whether GLP-1 use will drive more or less people to gyms. The need for gyms to adapt to accommodate GLP-1 users. A call for specialist coaches who understand GLP-1s. The fusion of fitness and wellness with traditional healthcare. The global adoption of GPL-1s. To learn more about Paul Byrne click here https://www.linkedin.com/in/paul-byrne-a930408/ To request a free copy of the Harrison Co report entitled: “The Impact and Opportunities of GLP-1s for the Fitness and Wellness Industry', visit Harrisonco.com ====================================================== Subscribe to our YouTube channel and turn on your notifications so you never miss a new video when it's published: https://www.youtube.com/user/EscapeFitness Shop gym equipment: https://escapefitness.com/shop View our full catalog:  https://escapefitness.com/support/catalog https://escapefitness.com/support/catalogue  ====================================================== Facebook: https://www.facebook.com/Escapefitness Instagram: https://www.instagram.com/escapefitness Twitter: https://www.twitter.com/escapefitness LinkedIn: https://www.linkedin.com/company/escapefitness/

La créatine Kré-Alkalyn de la marque EFX prétend fournir 28% de gains de force supplémentaires par rapport à la créatine monohydrate. Le fabricant affirme que cette forme de créatine est "la seule créatine garantie pour rester 100 % stable jusqu'à la cellule musculaire"; qu'elle est "jusqu'à dix fois plus puissante que la créatine ordinaire"; que "1,5 gramme de Kre-Alkalyn équivaut à environ 10 à 15 grammes de créatine ordinaire"; qu'elle est "une alternative à tous les ballonnements, crampes et autres effets secondaires associés à la supplémentation traditionnelle en créatine"; et, qu'elle est "la créatine la plus puissante au monde". Est-ce que tout cela est vrai ? C'est ce que l'on découvre dans le podcast de cette semaine Références: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500725/ https://pubmed.ncbi.nlm.nih.gov/20521064/ Site du fabricant: https://efxsports.com/product/kre-alkalyn-efx-capsules/

This weeks album review is from a hip-hop duo who came stiggedy-stomping onto the scene in 1992, named Das EFX with their debut LP Dead Serious. Rocking dreads, making tons of pop culture refrences, and putting as many “iggedys”after words as they could, Krazy Drazy and Skoob ushered in a brand new style never heard in hip-hop before and took the world by storm. https://instagram.com/str8_the_clippa?igshid=MzMyNGUyNmU2YQ%3D%3D&utm_source=qr https://www.facebook.com/profile.php?id=100086006336425&mibextid=LQQJ4d https://www.tiktok.com/@brandonhetzel996?_t=8hsW4qkVoWw&_r=1

Nuestro Insólito Universo _ Rey de los EFX especiales. En los cinco minutos de duración que tiene este programa se narran historias asombrosas referentes a cualquier tema. La primera transmisión de este programa se realizó por la Radio Nacional de Venezuela el 4 de agosto de 1969 y su éxito fue tal que, posteriormente, fue transmitido también por Radio Capital y, actualmente, se mantiene en la Radio Nacional (AM) y en los circuitos Éxitos y Onda, de Unión Radio (FM), lo cual le otorga una tribuna de red AM y FM que cubren todo el país, uno de los programas radiales más premiados y de mayor duración en la historia de la radio de Venezuela.

Chris Zippel & Tim Angrave, Javano, Smolny, Felix, Dual Monitor & Mulholland are a few of the artists who have new releases featured in this weeks show. Edits, EFX, embellishments and vocal drops a-plenty, on this week's Dub Intervention.Tune into new broadcasts of Dub Intervention, Saturday from 8 - 10 PM EST / 1 - 3 AM GMT (Sunday).For more info visit: https://thefaceradio.com/dub-intervention///Dig this show? Please consider supporting The Face Radio: http://support.thefaceradio.com Support The Face Radio with PatreonSupport this show http://supporter.acast.com/thefaceradio. Join the family at https://plus.acast.com/s/thefaceradio. Hosted on Acast. See acast.com/privacy for more information.

S01E20 - "Season Finale" - The David Cassidy Show hosted by award winning DJ Timm McCoy. Today's show is 3 Different albums. "Didn't You Used To Be...David Cassidy", "The Partridge Family - "Bulletin Board Album" and David Cassidy "Songs My Father Taught Me". Each show is compiled of all the music that David has ever recorded. From Stage/Screen/Movies From Partridge to EFX to Adam 11 to "Songs My Father Taught Me". Timm was dear friends with David for 28 years until his untimely death. They spent time with each other, shared letters, calls and friends. This show is for the Fans of David who Timm calls "Cassidians". With much Love & Respect. EMAIL: Timm@TimmMcCoy.com HAPPY TRAILS, BABY BLUE!

S01E19 - The David Cassidy Show hosted by award winning DJ Timm McCoy. Today's show 3 Different albums. Each show is compiled of all the music that David has ever recorded. From Stage/Screen/Movies From Partridge to EFX to Adam 11 to "Songs My Father Taught Me". Timm was dear friends with David for 28 years until his untimely death. They spent time with each other, shared letters, calls and friends. This show is for the Fans of David who Timm calls "Cassidians". With much Love & Respect. EMAIL: Timm@TimmMcCoy.com HAPPY TRAILS, BABY BLUE!

Last year, Stephen Harrison expounded on a string of press releases presaging some of the most promising data of the last decade in NASH drug development. As Principal Investigator, he reviewed on the podcast Phase 2b results from Akero's HARMONY Trial. This is a 24-week study evaluating the efficacy and safety of the FGF-21 agonist efruxifermin (EFX) in patients with clinically relevant NASH (F2-F3). The study met its primary endpoint for both the 50mg and 28mg EFX dose groups. Respectively, 41% and 39% of EFX-treated patients experienced at least a one-stage improvement in liver fibrosis with no worsening of NASH by week 24 (compared with 20% for the placebo arm).Stephen walks through his presentation on Akero's lead product candidate EFX and two important points emerge. First, Stephen and Sven Francque share the idea that “not all FGF-21's are created equal.” FGF-21's themselves need to be stabilized due to their two-hour half-lives. The first FGF-21, pegbelfermin, was PEGylated and revealed significant challenges in clinical development. EFX is a bivalent structure – two molecules stabilized by a fusion protein. This appears to work far better. The conversation continues with more points and questions about the study results and implications. An interesting idea surfaces: EFX might function better as an induction therapy to be followed by an oral maintenance therapy and a long-term monotherapeutic solution. As the session winds down, the group speculate the dynamics of what happens when disease regresses to a point where there is far less liver damage.

S01E18 - The David Cassidy Show hosted by award winning DJ Timm McCoy. 20 Shows a Season. Each show is compiled of all the music that David has ever recorded. From Stage/Screen/Movies From Partridge to EFX to Adam 11 to "Songs My Father Taught Me". Timm was dear friends with David for 28 years until his untimely death. They spent time with each other, shared letters, calls and friends. This show is for the Fans of David who Timm calls "Cassidians". With much Love & Respect. EMAIL: Timm@TimmMcCoy.com HAPPY TRAILS, BABY BLUE!

S01E17 - "Christmas In July Show" We salute Christmas on July 23rd. All music from "The Partridge Family Christmas Card" album and "The David Cassidy "Christmas" album. The David Cassidy Show hosted by award winning DJ Timm McCoy. 20 Shows a Season. Each show is compiled of all the music that David has ever recorded. From Stage/Screen/Movies From Partridge to EFX to Adam 11 to "Songs My Father Taught Me". Timm was dear friends with David for 28 years until his untimely death. They spent time with each other, shared letters, calls and friends. This show is for the Fans of David who Timm calls "Cassidians". With much Love & Respect. EMAIL: Timm@TimmMcCoy.com HAPPY TRAILS, BABY BLUE!

S01E15 - The David Cassidy Show hosted by award winning DJ Timm McCoy. 20 Shows a Season. Each show is compiled of all the music that David has ever recorded. From Stage/Screen/Movies From Partridge to EFX to Adam 11 to "Songs My Father Taught Me". Timm was dear friends with David for 28 years until his untimely death. They spent time with each other, shared letters, calls and friends. This show is for the Fans of David who Timm calls "Cassidians". With much Love & Respect. EMAIL: Timm@TimmMcCoy.com HAPPY TRAILS, BABY BLUE!

S01E13 - 7/2/23 No Partridge Family today. Only David and 4 off of each album for The Fourth Of July. No Requests to give Timm a holiday break. The David Cassidy Show hosted by award winning DJ Timm McCoy. 20 Shows a Season. Each show is compiled of all the music that David has ever recorded. From Stage/Screen/Movies From Partridge to EFX to Adam 11 to "Songs My Father Taught Me". Timm was dear friends with David for 28 years until his untimely death. They spent time with each other, shared letters, calls and friends. This show is for the Fans of David who Timm calls "Cassidians". With much Love & Respect. EMAIL: Timm@TimmMcCoy.com HAPPY TRAILS, BABY BLUE!

S01E12 - News about an interview Timm will have with The Hudson Brothers reuniting after 42 years and a possible tour? Live webcast? The David Cassidy Show hosted by award winning DJ Timm McCoy. 20 Shows a Season. Each show is compiled of all the music that David has ever recorded. From Stage/Screen/Movies From Partridge to EFX to Adam 11 to "Songs My Father Taught Me". Timm was dear friends with David for 28 years until his untimely death. They spent time with each other, shared letters, calls and friends. This show is for the Fans of David who Timm calls "Cassidians". With much Love & Respect. EMAIL: Timm@TimmMcCoy.com HAPPY TRAILS, BABY BLUE!

S01E11 - The David Cassidy Show hosted by award winning DJ Timm McCoy. 20 Shows a Season. Each show is compiled of all the music that David has ever recorded. From Stage/Screen/Movies From Partridge to EFX to Adam 11 to "Songs My Father Taught Me". Timm was dear friends with David for 28 years until his untimely death. They spent time with each other, shared letters, calls and friends. This show is for the Fans of David who Timm calls "Cassidians". With much Love & Respect. EMAIL: Timm@TimmMcCoy.com HAPPY TRAILS, BABY BLUE!

S01E10 - The David Cassidy Show hosted by award winning DJ Timm McCoy. 20 Shows a Season. Each show is compiled of all the music that David has ever recorded. From Stage/Screen/Movies From Partridge to EFX to Adam 11 to "Songs My Father Taught Me". Timm was dear friends with David for 28 years until his untimely death. They spent time with each other, shared letters, calls and friends. This show is for the Fans of David who Timm calls "Cassidians". With much Love & Respect. EMAIL: Timm@TimmMcCoy.com HAPPY TRAILS, BABY BLUE!

S01E09 - The David Cassidy Show hosted by award winning DJ Timm McCoy. 20 Shows a Season. Each show is compiled of all the music that David has ever recorded. From Stage/Screen/Movies From Partridge to EFX to Adam 11 to "Songs My Father Taught Me". Timm was dear friends with David for 28 years until his untimely death. They spent time with each other, shared letters, calls and friends. This show is for the Fans of David who Timm calls "Cassidians". With much Love & Respect. EMAIL: Timm@TimmMcCoy.com HAPPY TRAILS, BABY BLUE!

S01E08 - The David Cassidy Show hosted by award winning DJ Timm McCoy. 20 Shows a Season. Each show is compiled of all the music that David has ever recorded. From Stage/Screen/Movies From Partridge to EFX to Adam 11 to "Songs My Father Taught Me". Timm was dear friends with David for 28 years until his untimely death. They spent time with each other, shared letters, calls and friends. This show is for the Fans of David who Timm calls "Cassidians". With much Love & Respect. EMAIL: Timm@TimmMcCoy.com HAPPY TRAILS, BABY BLUE!

S01E07 - The David Cassidy Show hosted by award winning DJ Timm McCoy. 20 Shows a Season. Each show is compiled of all the music that David has ever recorded. From Stage/Screen/Movies From Partridge to EFX to Adam 11 to "Songs My Father Taught Me". Timm was dear friends with David for 28 years until his untimely death. They spent time with each other, shared letters, calls and friends. This show is for the Fans of David who Timm calls "Cassidians". With much Love & Respect. EMAIL: Timm@TimmMcCoy.com HAPPY TRAILS, BABY BLUE!

S01E06 - The David Cassidy Show hosted by award winning DJ Timm McCoy. 20 Shows a Season. Each show is compiled of all the music that David has ever recorded. From Stage/Screen/Movies From Partridge to EFX to Adam 11 to "Songs My Father Taught Me". Timm was dear friends with David for 28 years until his untimely death. They spent time with each other, shared letters, calls and friends. This show is for the Fans of David who Timm calls "Cassidians". With much Love & Respect. EMAIL: Timm@TimmMcCoy.com HAPPY TRAILS, BABY BLUE!

S01E05 - The David Cassidy Show hosted by award winning DJ Timm McCoy. 20 Shows a Season. Each show is compiled of all the music that David has ever recorded. From Stage/Screen/Movies From Partridge to EFX to Adam 11 to "Songs My Father Taught Me". Timm was dear friends with David for 28 years until his untimely death. They spent time with each other, shared letters, calls and friends. This show is for the Fans of David who Timm calls "Cassidians". With much Love & Respect. EMAIL: Timm@TimmMcCoy.com HAPPY TRAILS, BABY BLUE!

S01E04 - The David Cassidy Show hosted by award winning DJ Timm McCoy. 20 Shows a Season. Each show is compiled of all the music that David has ever recorded. From Stage/Screen/Movies From Partridge to EFX to Adam 11 to Songs My Father Taught Me. Timm was dear friends with David for 28 years until his untimely death. They spent time with each other, shared letters, calls and friends. This show is for the Fans of David who Timm calls "Cassidians". With much Love & Respect. EMAIL: Timm@TimmMcCoy.com HAPPY TRAILS, BABY BLUE!

S01E03 - The David Cassidy Show hosted by award winning DJ Timm McCoy. 20 Shows a Season. Each show is compiled of all the music that David has ever recorded. From Stage/Screen/Movies From Partridge to EFX to Adam 11 to Songs My Father Taught Me. Timm was dear friends with David for 28 years until his untimely death. They spent time with each other, shared letters, calls and friends. This show is for the Fans of David who Timm calls "Cassidians". With much Love & Respect. EMAIL: Timm@TimmMcCoy.com HAPPY TRAILS, BABY BLUE!

S01E02 - The David Cassidy Show hosted by award winning DJ Timm McCoy. 20 Shows a Season. Each show is compiled of all the music that David has ever recorded. From Stage/Screen/Movies From Partridge to EFX to Adam 11 to Songs My Father Taught Me. Timm was dear friends with David for 28 years until his untimely death. They spent time with each other, shared letters, calls and friends. This show is for the Fans of David who Timm calls "Cassidians". With much Love & Respect. EMAIL: Timm@TimmMcCoy.com HAPPY TRAILS, BABY BLUE!

S01E01 - The David Cassidy Show hosted by award winning DJ Timm McCoy. 20 Shows a Season. Each show is compiled of all the music that David has ever recorded. From Stage/Screen/Movies From Partridge to EFX to Adam 11 to Songs My Father Taught Me. Timm was dear friends with David for 28 years until his untimely death. They spent time with each other, shared letters, calls and friends. This show is for the Fans of David who Timm calls "Cassidians". With much Love & Respect. EMAIL: Timm@TimmMcCoy.com HAPPY TRAILS, BABY BLUE!

Last month, Stephen Harrison joined the Surf to cover a recent string of press releases presaging some of the most promising data of the last decade in NASH drug development. As Principal Investigator, he reviewed Phase 2b results from Akero's HARMONY Trial. This is a 24-week study evaluating the efficacy and safety of the FGF-21 agonist efruxifermin (EFX) in patients with clinically relevant NASH (F2-F3). The topline results he previously shared:The study met its primary endpoint for both the 50mg and 28mg EFX dose groups.Respectively, 41% and 39% of EFX-treated patients experienced at least a one-stage improvement in liver fibrosis with no worsening of NASH by week 24 (compared with 20% for the placebo arm).In this follow-up conversation, Stephen walks through his presentation on Akero's lead product candidate EFX. After detailing the data, two important points emerge. First, Stephen and Sven Francque share the idea that “not all FGF-21's are created equal.” FGF-21's themselves need to be stabilized due to their two-hour half-lives. The first FGF-21, pegbelfermin, was PEGylated and revealed significant challenges in clinical development. EFX is a bivalent structure - two molecules stabilized by a fusion protein. This appears to work far better. The conversation continues with more points and questions about the study results and implications. An interesting idea surfaces: EFX might function better as an induction therapy to be followed by an oral maintenance therapy as a long-term monotherapeutic solution. As the session winds down, the group speculate the dynamics of what happens when disease regresses to a point where there is far less liver damage.

This week attendees from around the world convened at the 73rd Annual AASLD Liver Meeting  for a lively and momentous event in Washington DC. On the final morning, Stephen Harrison, Sven Francque, Jörn Schattenberg, Ian Rowe and Jeff McIntyre join Roger Green to discuss key takeaways. Sven is first to expand on a presentation that struck notable interest. He chooses to highlight a presentation by Laurent Castera, which Mazen Noureddin anticipated in our preview coverage. This focuses on a prospective head-to-head comparison of the different non-invasive tests in a large cohort of T2D patients with NAFLD. The paper concluded that F-AST and MAST scores outperformed MEFIB, FIB-4 and NFS for identifying fibrotic NASH in T2D patients with NAFLD. Stephen broadens Sven's analysis by noting F-AST as a standout test that is generally available for multiple different applications. The group puts forth commentary on the cost effectiveness and accuracy of these tests within enriched populations. As this subject winds down, Ian points to the particular challenge of selecting patients for treatment. The reality, he says, is that it's not a one size fits all approach. The conversation transitions from diagnostics to the topic of drugs. Stephen  walks through his presentation on the efficacy and safety of Akero's lead product candidate efruxifermin (EFX) in patients with clinically relevant NASH (F2-F3). The results point to EFX significantly improving liver histology, liver fat content and noninvasive markers of liver injury, fibrosis, and glucose and lipid metabolism in patients with F2/F3 fibrosis due to NASH. Stephen shares his optimism for this particular FGF-21 agonist while Sven agrees that “not all FGF-21's are created equal.” The group explores the science behind the structure of the EFX compound before Roger recalls the question of where the right use for such a drug might exist. It's been previously suggested on this podcast that a medication not entirely suited for long-term therapy due to cost, dosing or side effects might serve best as induction therapy. With this in mind, the group addresses the dynamics of what happens when disease regresses to a point where there is far less liver damage. From here, Roger introduces a brief assessment of Arun Sanyal's presentation of topline results from a new analysis of the REGENERATE Trial.The last major theme in this episode involves the Nomenclature session. Jeff offers an objective account of how this subject reported before disclosing some concerns from the patient perspective. His primary concern lies in coming to a decision that causes regulatory agencies to require new clinical trials, thereby slowing approvals by several years. The other panelists respond with their impressions and the consensus is that virtually nobody is in favor of a name change at this point in time if it stands in the way of progressing drugs and diagnostics.The breadth, quality and novelty of this conversation reflects yet another exceptional and positive Liver Meeting, this time back in person. In lieu of the typical business report, Roger and Stephen conduct a special interview with Michael Cooreman from Inventiva. The three discuss the work of this clinical-stage biopharmaceutical company and its relevance to Fatty Liver. Inventiva develops novel and differentiated oral small molecule therapies for patients suffering from diseases with significant unmet medical need. The discussion centers mostly around clinical trial development for the pan-PPAR lanifibranor.  

A classic from PRE-LOTR Jackson. Funny, scary, moving. EFX hold up and the story works. #31daysofhalloweenmovies #thefrighteners #michaeljfox --- Send in a voice message: https://anchor.fm/toddlyden/message

A recent string of press releases presaged some of the most exciting, promising data of the last decade in NASH drug development. In this conversation, Principal Investigator Stephen Harrison reviews Phase 2b results from Akero's HARMONY Trial. Special guest Mazen Noureddin joins Jörn Schattenberg, Louise Campbell and Roger Green to share impressions. This conversation starts with Stephen returning to his discussion of Altimmune's dual GLP-1/glucagon agonist, pemvidutide. He comments that stock analysts appear to have punished Altimmune because pemvidutide did not demonstrate greater weight loss. He considers this an inaccurate read. He notes that the 12 week weight loss results of pemvidutide are comparable with 24 weeks with efruxifermin (EFX) in the extremely successful HARMONY Trial. Stephen then segues to detail HARMONY, a 24-week study evaluating the efficacy and safety of the FGF-21 agonist EFX in patients with clinically relevant NASH (F2-F3). The topline results:The study met its primary endpoint for both the 50mg and 28mg EFX dose groups. Respectively, 41% and 39% of EFX-treated patients experienced at least a one-stage improvement in liver fibrosis with no worsening of NASH by week 24 (compared with 20% for the placebo arm). Stephen notes the presence of key secondary endpoints and important demographics of the patients. He also describes the program for histological analysis and goes on to highlight some extremely positive - perhaps eye-opening - results. Mazen and Jörn react by describing these two results as a Wow! episode. Louise adds comments on the potential for the NIT analysis to speed the transition beyond the biopsy.

A recent string of press releases presaged some of the most exciting, promising data of the last decade in NASH drug development. In this conversation, Stephen Harrison continues his review of Phase 2B results from Akero's HARMONY Trial before introducing more positive Phase 2B results from a study by Poxel. Mazen Noureddin, Jörn Schattenberg, Louise Campbell and Roger Green share impressions.  Mazen asked whether the future must rely on combination therapies. The question leads Roger back to a comment Akero Chief Development Officer, Kitty Yale, made in a January 2021 podcast. She stated that Akero believes the future of NASH therapy might not hinge on combination therapies. Stephen suggests it prudent to continue following these results as it might be premature to discuss how this drug will be applied. The uncertainty stems from questions around the drug's modes of action and delivery, potential for tolerability issues or possible reduction of effect over time. Roger asks whether this drug, like BMS's pegbelfermin, might wear off over time. Stephen suggests that differences in the chemical structure of these two FGF-21 agents points that EFX might not do so. He explains how a drug like EFX could serve as induction therapy followed by a lower cost, better tolerated oral agent. The conversation shifts to the next set of data produced by Poxel. The DESTINY-1 study reports positive histology results for PXL065, a novel, proprietary deuterium-stabilized R-stereoisomer of pioglitazone. Stephen elucidates on the science of this drug and the mechanics of deuterium as a stabilizer. The study design consists of 117 subjects across four cohorts: three different doses versus placebo. The trial met its primary efficacy endpoint for liver fat content reduction at 36 weeks for all doses. Louise emphasizes the positives associated with delivering an oral mechanism.

A recent string of press releases has presaged some of the most exciting, promising data of the last decade in NASH drug development. In this episode,  Stephen Harrison reviews recent press releases from Altimmune, Akero, Poxel, Axcella and Intercept, while Jörn Schattenberg, Louise Campbell, special guest Mazen Noureddin and Roger Green share questions and impressions. Last month, Altimmune presented its top-line results of a 12 week Phase 1B study of pemvidutide, a GLP-1/glucagon dual receptor agonist. After outlining the study design, Stephen summarizes the positive results of liver fat content reduction. Jörn takes interest in extending the spectrum of GLP-1s by targeting the liver directly with a glucagon agonist. Mazen notes liver fat reduction as disproportionately higher than what is typically seen in a 4.3% weight loss scenario. He expresses optimism that drug's positive impact on other metabolic parameters suggests a "whole body approach." The three then contextualize overall weight loss and liver fat content reductions. The conversation shifts to Phase 2b results from Akero's HARMONY Trial.  HARMONY met its primary endpoint for both the 50mg and 28mg EFX dose groups, with 41% and 39% of EFX-treated patients experiencing at least a one-stage improvement in liver fibrosis with no worsening of NASH at week 24, (vs. 20% for the placebo arm). This leads Mazen to ask whether the future must rely on combination therapies.  This leads Roger to recall a similar suggestion from Akero Chief Development Officer on a January 2021 episode. Stephen points out that future therapy might look not only at point-in-time combinations but also sequences of induction and maintenance therapies, as with many cancers.The next set of data comes from DESTINY-1, a paired liver biopsy Phase 2B trial from Poxel. This study reports positive histology results for PXL065, a novel, proprietary deuterium-stabilized R-stereoisomer of pioglitazone. Stephen elucidates on the science of this drug and the mechanics of deuterium as a stabilizer. The study design consists of 117 subjects across four cohorts: three different doses versus placebo. The trial met its primary efficacy endpoint for liver fat content reduction at 36 weeks for all doses. Louise emphasizes the positives associated with delivering an oral mechanism. Roger expresses enthusiasm that introducing multiple modes of action to the market will create the energy and investment to drive a dynamic explosion of education and exploration in Fatty Liver diseases.The panel continues exploring oral drugs by reviewing positive interim data from the Phase 2b EMMPACT Study by Axcella. They discuss the broad activity of this drug in addition to its well-tolerated profile and safety. On a less optimistic note, Stephen outlines the Phase 3 results of the REVERSE trial by Intercept. This study focuses on evaluating the safety and efficacy of OCA in patients with compensated cirrhosis and, ultimately, did not meet its primary endpoint.Dubbed a Wow! episode by the panelists, there are plenty more observations and supporting data points to be explored in this discussion. Surf on for the full report.

2 weeks in a row, can you believe it? Evelyn and Chris are back and they discuss this issue with this Pumpkin Spice outrage and then go off on Offer Up and what Chris needs to sell so Evelyn can park her car in the garage. @Chris_Donovan @EvelynErives#ThisIsFunner #FunnerFamily #FunnerNetworkhttps://twitter.com/ThisIsFunnerhttps://www.facebook.com/ThisIsFunner/

S&P Futures after being positive all morning, futures have just gone negative. There are a host of companies scheduled to release their earnings this morning including NTRS, NDAQ, BKR, BIIB, and ABT. After the bell today we will be hearing from SLG, AA, UAL, EFX, LVS, DFS, CSX, CCI, and TSLA. After the opening bell this morning we have economic reports on Existing Home Sales and the official EIA stockpiles report. News reports indicate that mortgage demand has dropped to a 22 year low.

My friend and visual artist extraordinaire, Dominique Darko, joins me for an insightful conversation about the uncontrollable urge to create and turning your passions into a career. We also discuss our mutual love for all things pop-culture and the influence it has had in our lives both personally and professionally over the years. Enjoy! Check out Dominique's work: https://www.instagram.com/dominiquedarko/ The audio only version of this episode is available on Spotify, Apple and pretty much anywhere else podcasts are found. Just search for 'Start The Beat Podcast'.

Hey there, deadites! Join us and "fan favorite" Aidan as we discuss, undoubtedly our favorite entry in the Friday the 13th series, The Final Chapter. With better writing, better characters, better kills, and better EFX from the legendary Tom Savini, see why it's beloved by most, and us!

Evelyn makes a new dish for the family called Edamame Pesto Gluten Free Pasts with Chicken. Then Chris and her discuss the hottest shows to watch on TV right now! @Chris_Donovan @EvelynErives#ThisIsFunner #FunnerFamily #FunnerNetworkhttps://twitter.com/ThisIsFunnerhttps://www.facebook.com/ThisIsFunner/

In this episode of LIGHT TALK, The Lumen Brothers (and Sistah!) celebrate their 5th Anniversary with friend and lighting designer extraordinair, Natasha Katz.   Join Natasha, Ellen, Stan, David, and Steve, as they pontificate about: Natasha's journey into lighting design; Favorite light sources; "MJ" The Michael Jackson musical; Dealing with "four-wall" Broadway shows; "Diana" - adapting a show for streaming; Giving birth to, and during, "EFX"; Lighting The Boss on Broadway; Collaborating with Christopher Wheeldon; Working with video designers; and Advice for young lighting designers.    Nothing is Taboo, Nothing is Sacred, and Very Little Makes Sense.

Doug Voet has an illustrious stage career appearing in numerous productions. Singer, actor, producer, horse lover and close friend of David's, they met in 1983 when David took over the lead role on Broadway in Joseph and the Amazing Technicolor Dreamcoat. Doug taught David the role and their friendship grew. Some years later David, who was starring in EFX in Las Vegas, offered Doug a new direction in his career inviting him to produce a new show, At The Copa, he had created. They also worked together on The Rat Pack Is Back and Doug went on to be David's tour manager on his US and UK tours. Cherish David Cassidy A Legacy of Love by Louise Poynton is available from Amazon and can be ordered instore or online from all bookstores.

In this 11th episode of the Max EFX Podcast, Max Cervantes and Kevin Toft talk with three very special guests who have all worked on one of the biggest box office successes of 2022 - Jackass Forever. Max and his friends Bobby Doran, Jeff Cupernell and Nikki Freed discuss what it was like to create a 25-ft square city model city at Vision Scenery Studios in Los Angeles, CA.    The guests “squid out” with Max and Kevin in this free-flowing conversation and reveal their personal easter eggs hidden in their work. If you've seen any of the films in the Jackass franchise you know what you're in for. And it goes without saying we don't condone any of the jackass stunts performed in these films.   Join us on this next leg of the journey!   Join the Max EFX Facebook Group!   Listen on Apple Podcasts | Google Podcasts | Spotify | Amazon Music   The Max EFX Podcast is part of the Skywalking Network.  

In this 11th episode of the Max EFX Podcast, Max Cervantes and Kevin Toft talk with three very special guests who have all worked on one of the biggest box office successes of 2022 - Jackass Forever. Max and his friends Bobby Doran, Jeff Cupernell and Nikki Freed discuss what it was like to create a 25-ft square city model city at Vision Scenery Studios in Los Angeles, CA.    The guests “squid out” with Max and Kevin in this free-flowing conversation and reveal their personal easter eggs hidden in their work. If you've seen any of the films in the Jackass franchise you know what you're in for. And it goes without saying we don't condone any of the jackass stunts performed in these films.   Join us on this next leg of the journey!   Join the Max EFX Facebook Group!   Listen on Apple Podcasts | Google Podcasts | Spotify | Amazon Music   The Max EFX Podcast is part of the Skywalking Network.  

Robyn Hadden was personal assistant to David Cassidy when he took over the starring role in EFX, the biggest show in Las Vegas in 1996. David replaced Michael Crawford who had hand-picked Robyn to be his personal assistant. She continued working in that role with David throughout his time in Vegas where he also was behind successful productions, At The Copa and The Rat Pack Is Back. When David returned to concerts, Robyn toured both the United States and the UK with him making lifelong friendships with many fans. Robyn had planned to be a pharmacist and explains her journey into the world of entertainment, later working in Special Events. She earned her Certified Special Events Professional (CSEP) designation in 2000 and her Masters Degree from the University of Nevada in 2005. She served as Director of Alumni & College Relations at the UNLV College of Hospitality and continued her career at the Ohio State University where she was Associate Director (Special Events).   In our amusing and, at times, emotional conversation, Robyn shares anecdotes from her years knowing David and explains why at 40 she decided to follow her dream of becoming a mother through IVF and an anonymous donor. She became mother to Jack in 2011, and later moved back to Ohio having met the love of her life. Click Here to Tweet Listen and Follow on Apple:  The David Cassidy Connections on Apple Podcasts Listen and Follow on Google: Google Podcasts - the david cassidy connections Listen and Follow on Spotify: The David Cassidy Connections | Podcast on Spotify Louise's Twitter @LouisePoynton David Cassidy Rocks @CassidyUnited Cherish David Cassidy A Legacy of Love is available from Amazon and all bookshops online or in store.

Welcome to the premiere of The Max EFX Podcast! Here we will journey through the career of Special Effects Artist, Max Cervantes. He shares stories from working on Star Trek TV and films, Beetlejuice, films by Roger Corman, the Star Wars Pepsi commercial, Waterworld, and so many more. Max also discusses the many roles he's played in the Star Trek Universe.    Get to know Max Cervantes and moderator, Kevin Toft, as they discuss how Max became intertwined in the Effects business. It all started with one teacher who went above and beyond for a student.   They also discuss their favorite Science Fiction and Fantasy fandoms going back to the days where science fiction conventions were held on just one day in a small room in a downtown hotel.   

A deep dive into the special effects industry with behind-the-scenes stories, how to create effects and how to get started. Hosted by Special EFX Artist Max Cervantes (Filmography includes Star Trek: TNG, DS9, Voyager, etc. / Beetlejuice / Masters of the Universe and more) and Kevin Toft, video game graphic designer. The Max EFX also explores past, present, and future Science Fiction and Fantasy fandoms.